Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by Trennamon Feb 03, 2021 9:57am
97 Views
Post# 32457242

RE:RE:RE:GW Pharma to Be Acquired for $220 Per Share

RE:RE:RE:GW Pharma to Be Acquired for $220 Per Share
This is funny. Years ago I thought: sooner or later there will be Cannabis Patent wars.

Usually a sign of a mature industry. The box has been opened and others are watching. This is a good and bad thing - now expect others to jump in on the action.

I have been in a company that did this - bought out another that had several lawsuits against it. Eventually they will have to settle or agree to drop all legal actions mutually.

One side will have to blink. However this can drag on for years.

So hope for a quick settlement and / or licensing type deal.






WestCoast78 wrote:

Jazz pharmaceuticals just paid a big premium to buy / inherit  that lawsuit.  Hopefully we win, and get paid retroactively.  Big risk on Jazz' part.

 

TinToronto wrote: What about Canopy's claim against GWP?  Pretty sure a piece of that $220 should be ours if they've been using Canopy's patents.

 

WestCoast78 wrote: USA deals happening.  Look at that premium paid!!  Seems like things are happening https://www.newcannabisventures.com/gw-pharma-to-be-acquired-for-220/

 




<< Previous
Bullboard Posts
Next >>